Study: Type 1 Diabetes Heart Ills Static
Posted on: Monday, 1 May 2006, 15:00 CDT
University of Pittsburgh scientists say rates of heart and eye disease in type 1 diabetics have not improved during the past 25 to 30 years.
Researchers said the study -- one of the most comprehensive, long-term studies associated with type 1 diabetes -- showed that while cases of premature death and a few other complications have declined, rates of other serious diabetes-related disorders such as heart and eye disease have not improved.
The investigators analyzed long-term complications such as mortality, renal failure and coronary artery disease in 906 type 1 diabetics participating in the Pittsburgh Epidemiology of Diabetes Complications Study between 1950 and 1980.
The scientists' analysis of mortality data showed those diagnosed in later years lived longer. Individuals diagnosed during the 1950s had a five times higher rate of early death at 25 years post-diagnosis than those diagnosed during the 1970s.
Some morbidity rates also were reduced; kidney-failure rates, for example, declined significantly for those diagnosed more recently. On the other hand, there were no differences across cohorts for rates of cardiovascular disease events and cardiac intervention procedures.
The study appears in the current issue of the journal Diabetes.
Source: United Press International
Related Articles
- Viral Genetics, Inc. Releases Initial Findings of Lyme Disease Study
- Sixty-One Percent of Newly Diagnosed Parkinson's Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
- Diabetes Disease Management Reviewed
- Type 2 diabetes teens have higher complication risk
- Wealthy Chinese Warned of a Rising Rate in Hepatitis Diseases
- Diagnosing Celiac Disease With a Positive Serological Test and Without an Intestinal Biopsy/In Reply
- Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study Report No. 27
- National Survey Finds High Rate of Kidney Disease, Other Health Problems, in People at Risk
- Comparing the Long-Term Cost-Effectiveness of Repaglinide Plus Metformin Versus Nateglinide Plus Metformin in Type 2 Diabetes Patients With Inadequate Glycaemic Control: An Application of the CORE Diabetes Model in Type 2 Diabetes
User Comments (0)

RSS Feeds